Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,850 | -182,051 | -182,137 | -103,951 | -33,015 |
| Depreciation Amortization | 5,024 | 17,409 | 11,573 | 7,628 | 3,829 |
| Accounts payable and accrued liabilities | -505 | -767 | 1,277 | 1,088 | 4,152 |
| Other Working Capital | -19,992 | -31,949 | -31,982 | -35,352 | -39,266 |
| Other Operating Activity | 27,086 | 12,546 | 61,893 | 40,089 | 14,972 |
| Operating Cash Flow | $-68,237 | $-184,812 | $-139,376 | $-90,498 | $-49,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,902 | -21,446 | -20,710 | -17,363 | -6,461 |
| Purchase Of Investment | -89,155 | -543,293 | -490,739 | -345,317 | -164,990 |
| Sale Of Investment | 68,680 | 728,394 | 645,854 | 484,072 | 268,249 |
| Investing Cash Flow | $-22,377 | $163,655 | $134,405 | $121,392 | $96,798 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,814 | 11,963 | 11,641 | 9,258 | 6,044 |
| Financing Cash Flow | $1,814 | $11,963 | $11,641 | $9,258 | $6,044 |
| Beginning Cash Position | 183,606 | 192,800 | 192,800 | 192,800 | 192,800 |
| End Cash Position | 94,806 | 183,606 | 199,470 | 232,952 | 246,314 |
| Net Cash Flow | $-88,800 | $-9,194 | $6,670 | $40,152 | $53,514 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,237 | -184,812 | -139,376 | -90,498 | -49,328 |
| Capital Expenditure | -1,902 | -21,446 | -20,710 | -17,363 | -6,461 |
| Free Cash Flow | -70,139 | -206,258 | -160,086 | -107,861 | -55,789 |